Global Chronic Obstructive Pulmonary Disorder Market Size, Status and Forecast 2022
This report studies the global Chronic Obstructive Pulmonary Disorder market, analyzes and researches the Chronic Obstructive Pulmonary Disorder development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- AstraZeneca
- Boehringer Ingelheim
- GSK
- Novartis
- Teva Pharmaceuticals
- Ache Laboratorios Farmaceuticos
- Almirall
- Aquinox Pharmaceuticals
- Ario Pharma
- Asmacure
- Astellas Pharma
- BioMarck Pharmaceuticals
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Short-Acting Bronchodilators
- Corticosteroids
- Methylxanthines
- Long-Acting Bronchodilators
- Phosphodiesterase-4 Inhibitors
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Chronic Obstructive Pulmonary Disorder Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER
1.1 Chronic Obstructive Pulmonary Disorder Market Overview
1.1.1 Chronic Obstructive Pulmonary Disorder Product Scope
1.1.2 Market Status and Outlook
1.2 Global Chronic Obstructive Pulmonary Disorder Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Chronic Obstructive Pulmonary Disorder Market by Type
1.3.1 Short-Acting Bronchodilators
1.3.2 Corticosteroids
1.3.3 Methylxanthines
1.3.4 Long-Acting Bronchodilators
1.3.5 Phosphodiesterase-4 Inhibitors
1.4 Chronic Obstructive Pulmonary Disorder Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISORDER COMPETITION ANALYSIS BY PLAYERS
2.1 Chronic Obstructive Pulmonary Disorder Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 AstraZeneca
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Boehringer Ingelheim
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GSK
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Novartis
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Teva Pharmaceuticals
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Ache Laboratorios Farmaceuticos
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Almirall
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Aquinox Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Ario Pharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Asmacure
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Astellas Pharma
3.12 BioMarck Pharmaceuticals
4 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2012-2017)
4.2 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2012-2017)
4.3 Potential Application of Chronic Obstructive Pulmonary Disorder in Future
4.4 Top Consumer/End Users of Chronic Obstructive Pulmonary Disorder
5 UNITED STATES CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
5.2 United States Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
6 EU CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
6.2 EU Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
7 JAPAN CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
7.2 Japan Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
8 CHINA CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
8.1 China Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
8.2 China Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
9 INDIA CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
9.1 India Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
9.2 India Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
10.2 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Chronic Obstructive Pulmonary Disorder Market Size (Value) by Regions (2017-2022)
11.1.1 United States Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.2 EU Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.3 Japan Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.4 China Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.5 India Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.2 Global Chronic Obstructive Pulmonary Disorder Market Size (Value) by Type (2017-2022)
11.3 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)
12 CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET DYNAMICS
12.1 Chronic Obstructive Pulmonary Disorder Market Opportunities
12.2 Chronic Obstructive Pulmonary Disorder Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Chronic Obstructive Pulmonary Disorder Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Chronic Obstructive Pulmonary Disorder Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER
1.1 Chronic Obstructive Pulmonary Disorder Market Overview
1.1.1 Chronic Obstructive Pulmonary Disorder Product Scope
1.1.2 Market Status and Outlook
1.2 Global Chronic Obstructive Pulmonary Disorder Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Chronic Obstructive Pulmonary Disorder Market by Type
1.3.1 Short-Acting Bronchodilators
1.3.2 Corticosteroids
1.3.3 Methylxanthines
1.3.4 Long-Acting Bronchodilators
1.3.5 Phosphodiesterase-4 Inhibitors
1.4 Chronic Obstructive Pulmonary Disorder Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISORDER COMPETITION ANALYSIS BY PLAYERS
2.1 Chronic Obstructive Pulmonary Disorder Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 AstraZeneca
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Boehringer Ingelheim
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GSK
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Novartis
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Teva Pharmaceuticals
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Ache Laboratorios Farmaceuticos
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Almirall
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Aquinox Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Ario Pharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Asmacure
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Chronic Obstructive Pulmonary Disorder Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Astellas Pharma
3.12 BioMarck Pharmaceuticals
4 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2012-2017)
4.2 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2012-2017)
4.3 Potential Application of Chronic Obstructive Pulmonary Disorder in Future
4.4 Top Consumer/End Users of Chronic Obstructive Pulmonary Disorder
5 UNITED STATES CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
5.2 United States Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
6 EU CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
6.2 EU Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
7 JAPAN CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
7.2 Japan Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
8 CHINA CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
8.1 China Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
8.2 China Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
9 INDIA CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
9.1 India Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
9.2 India Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA CHRONIC OBSTRUCTIVE PULMONARY DISORDER DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (2012-2017)
10.2 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Chronic Obstructive Pulmonary Disorder Market Size (Value) by Regions (2017-2022)
11.1.1 United States Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.2 EU Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.3 Japan Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.4 China Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.5 India Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2017-2022)
11.2 Global Chronic Obstructive Pulmonary Disorder Market Size (Value) by Type (2017-2022)
11.3 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)
12 CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET DYNAMICS
12.1 Chronic Obstructive Pulmonary Disorder Market Opportunities
12.2 Chronic Obstructive Pulmonary Disorder Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Chronic Obstructive Pulmonary Disorder Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Chronic Obstructive Pulmonary Disorder Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Chronic Obstructive Pulmonary Disorder Product Scope
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2017)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Regions in 2016
Figure United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Type in 2016
Figure Short-Acting Bronchodilators Market Size (Million USD) and Growth Rate (2012-2017)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2012-2017)
Figure Methylxanthines Market Size (Million USD) and Growth Rate (2012-2017)
Figure Long-Acting Bronchodilators Market Size (Million USD) and Growth Rate (2012-2017)
Figure Phosphodiesterase-4 Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2016 and 2017)
Figure Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table GSK Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Teva Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Teva Pharmaceuticals (2012-2017)
Figure Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Ache Laboratorios Farmaceuticos Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Ache Laboratorios Farmaceuticos (2012-2017)
Figure Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Almirall Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Almirall (2012-2017)
Figure Almirall Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Aquinox Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Aquinox Pharmaceuticals (2012-2017)
Figure Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Ario Pharma Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Ario Pharma (2012-2017)
Figure Ario Pharma Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Asmacure Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Asmacure (2012-2017)
Figure Asmacure Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Astellas Pharma Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Astellas Pharma (2012-2017)
Figure Astellas Pharma Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table BioMarck Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of BioMarck Pharmaceuticals (2012-2017)
Figure BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Type (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2012
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2013
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2014
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2015
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2016
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2017
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2012
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2013
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2014
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2015
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2016
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Chronic Obstructive Pulmonary Disorder
Figure United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure United States Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure United States Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure EU Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure EU Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure China Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure China Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure India Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure India Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Regions (2017-2022)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Regions (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2022
Figure United States Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Type (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2022
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2022
Figure Chronic Obstructive Pulmonary Disorder Product Scope
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2017)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Regions in 2016
Figure United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Type in 2016
Figure Short-Acting Bronchodilators Market Size (Million USD) and Growth Rate (2012-2017)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2012-2017)
Figure Methylxanthines Market Size (Million USD) and Growth Rate (2012-2017)
Figure Long-Acting Bronchodilators Market Size (Million USD) and Growth Rate (2012-2017)
Figure Phosphodiesterase-4 Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2016 and 2017)
Figure Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table GSK Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Teva Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Teva Pharmaceuticals (2012-2017)
Figure Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Ache Laboratorios Farmaceuticos Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Ache Laboratorios Farmaceuticos (2012-2017)
Figure Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Almirall Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Almirall (2012-2017)
Figure Almirall Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Aquinox Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Aquinox Pharmaceuticals (2012-2017)
Figure Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Ario Pharma Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Ario Pharma (2012-2017)
Figure Ario Pharma Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Asmacure Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Asmacure (2012-2017)
Figure Asmacure Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Astellas Pharma Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of Astellas Pharma (2012-2017)
Figure Astellas Pharma Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table BioMarck Pharmaceuticals Basic Information List
Table Chronic Obstructive Pulmonary Disorder Business Revenue (Million USD) of BioMarck Pharmaceuticals (2012-2017)
Figure BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Revenue Market Share in 2016
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Type (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2012
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2013
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2014
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2015
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2016
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2017
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2012
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2013
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2014
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2015
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2016
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Chronic Obstructive Pulmonary Disorder
Figure United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure United States Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure United States Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure EU Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure EU Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure China Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure China Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure India Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure India Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2016
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Share by Players in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Regions (2017-2022)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Regions (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2022
Figure United States Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Type (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type in 2022
Table Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2017
Figure Global Chronic Obstructive Pulmonary Disorder Market Size (Million USD) by Application in 2022
